Status:
UNKNOWN
CPET in Evaluation of PH in COPD Patients
Lead Sponsor:
Assiut University
Conditions:
COPD
Pulmonary Hypertension Secondary
Eligibility:
All Genders
40-80 years
Brief Summary
* To evaluate the entire course of exercise during CPET in COPD patients. * To study whether CPET, PFTs and arterial blood gases could discriminate between COPD patients with and without PH. * To stud...
Detailed Description
(COPD) is a common cause of pre-capillary pulmonary hypertension (PH). Pulmonary hypertension (PHT) is a common complication of COPD and is determinant for the prognosis of COPD. PHT is defined as A ...
Eligibility Criteria
Inclusion
- Stable COPD patients
- with age ≥ 40 years.
- Prior to inclusion, the COPD diagnosis was verified by spirometry before and after bronchodilation.
- treatment was optimized and Patients on regular medication.
Exclusion
- Patients who refuse to participate in the study.
- Patients underwent thorough pulmonary and cardiologic preinclusion screening, and those with pulmonary disease other than COPD and emphysema.
- arrhythmia
- valvular or coronary heart disease
- left ventricle dysfunction
- obstructive sleep apnea syndrome
- pulmonary embolism
- systemic hypertension ≥160/90 mmHg
- inflammatory disease
- hyperthyroidism
- renal failure
- inability to exercise (due to orthopedic, neurologic or musculoskeletal problem).
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04035148
Start Date
October 1 2019
End Date
October 1 2021
Last Update
July 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.